论文信息 - Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer - 字舞流文

Sarcopenia and high NLR are associated with the development of hyperprogressive disease after second‐line pembrolizumab in patients with non‐small‐cell lung cancer

M. Petrova | N. Conev | I. Donev | M. Radanova | C. Timcheva | B. Robev | V. Megdanova | E. Dimitrova | M. Eneva | Geogi N Valchev | V. Minchev | M. Taushanova | Marsella Boneva | Teodora S Karanikolova | Radostina B Gencheva | Georgi A Zhbantov | Anika I. Ivanova | Boian Pavlov